There are 807 resources available
1MO - The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) in Chinese patients (pts) with HER2-positive early breast cancer (EBC): Primary analysis of the phase III, randomised FDChina study
Presenter: Zhimin Shao
Session: Mini Oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
227MO - Characterization of minimal residual disease (MRD) post-radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients identifies a favorable subgroup with low risk of relapse
Presenter: Jialing Neo
Session: Mini Oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Advances targeting HER family
Presenter: Funda Meric-Bernstam
Session: A peek into the future of precision medicine
Resources:
Slides
Webcast
Hormone-sensitive metastatic prostate cancer
Presenter: Nobuaki Matsubara
Session: Front-line combination treatments in GU malignancies: How do we decide?
Resources:
Slides
Webcast
Discussion led by the Chairs
Presenter: Won Seog Kim
Session: Management of haematological neoplasia in the era of COVID-19
Resources:
Webcast
322MO - Amivantamab in combination with lazertinib in patients with atypical epidermal growth factor receptor (EGFR) mutations excluding exon 20 insertion mutations: Initial results from CHRYSALIS-2
Presenter: Byoung Chul Cho
Session: Mini Oral session: Thoracic cancers
Resources:
Abstract
Slides
Webcast
2MO - Final analysis of the phase III randomized clinical trial, comparing HD201 vs referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting
Presenter: Xavier Pivot
Session: Mini Oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
226MO - Is induction chemotherapy beneficial in locally recurrent nasopharyngeal carcinoma before re-irradiation? A multicenter retrospective analysis
Presenter: yan wenbin
Session: Mini Oral session: Head and neck cancer
Resources:
Abstract
Slides
Proteosomal degraders
Presenter: Udai Banerji
Session: A peek into the future of precision medicine
Resources:
Slides
Webcast
Urothelial cancer
Presenter: Enrique Grande Pulido
Session: Front-line combination treatments in GU malignancies: How do we decide?
Resources:
Slides
Webcast